2020 American Transplant Congress
HCV Viremic Kidneys for Uninfected Recipients with DAA Treatment Offers Sustained Virologic Response
Montefiore Medical Center, Bronx, NY
*Purpose: Development of direct acting anti-viral medications (DAA) have offered cure rates for hepatitis C infection (HCV) approaching 100%. This has provided the ability to…2020 American Transplant Congress
Is Bridging Anticoagulation or Antiplatelet Reversal Necessary Prior to Kidney Transplantation?
AHN Transplant Institute, Allegheny General Hospital, Pittsburgh, PA
*Purpose: Pre-kidney transplant patients are often placed on anticoagulation or antiplatelet therapy, and their perioperative management is often challenging. The aim of this study is…2020 American Transplant Congress
Understanding the Decision-Making of 2576 Potential Living Kidney Donors of Different Racial/Ethnic Backgrounds
*Purpose: To better understand racial/ethnic disparities associated with kidney living donation, this study examined differences in potential living kidney donors’ decision-making, resistance to donation, and…2020 American Transplant Congress
Assessment of Time to Therapeutic Tacrolimus Levels Following Renal Transplantation in a Non-Weight-Based Dosing Model
*Purpose: The optimal initial dose for tacrolimus (TAC) after renal transplant (RT) remains controversial with limited evidence comparing weight-based and conservative strategies. Recent literature suggests…2020 American Transplant Congress
Evaluating the Efficacy of Robotic-Assisted Incisional Hernia Repair for Post-Liver Transplant Recipients
University of Utah, Salt Lake City, UT
*Purpose: Hernia formation is a well-known complication following open abdominal surgery that contributes to post-operative morbidity and decreases in patient quality of life. Herein we…2020 American Transplant Congress
Temporal Trends in Utilization and Outcomes of DCD Livers for Liver Transplantation in the United States
Johns Hopkins University, Baltimore, MD
*Purpose: Donation after cardiac death (DCD) livers represent a possible expansion to the donor pool, but are frequently discarded due to an increased mortality and…2020 American Transplant Congress
Effect of 2015 T2 Hepatocellular Carcinoma Exception Policy Implementation on Waitlist Time and Tumor Characteristics
*Purpose: A United Network for Organ Sharing (UNOS) policy change in 2015 created a 6-month delay in the receipt of T2 hepatocellular carcinoma (HCC) exception…2020 American Transplant Congress
Impact of Donation after Circulatory Death Allografts on Outcomes Following Liver Re-Transplantation in the United States
*Purpose: Scarcity of donor organs in liver transplantation (LT) has necessitated consideration of donation after circulatory death (DCD) donors. Complications following LT and disease recurrence…2020 American Transplant Congress
Performance Evaluation of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates
University of Arizona College of Medicine Phoenix, Phoenix, AZ
*Purpose: The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) tool is employed in candidate evaluation. SIPAT scoring and association with outcomes post liver transplant (LT)…2020 American Transplant Congress
High Rate of Positive Cultures from Deceased Donors, A Review of 500 Deceased Donors and More Than 700 Recipients from a Single Center in Saudi Arabia
*Purpose: Limited organ supply is one of the major challenges facing organ transplantation. Donor-derived multidrug-resistant (MDR) bacteria have been documented with variable outcomes. In Saudi…
- 1
- 2
- 3
- …
- 223
- Next Page »